Suppr超能文献

乳房切除术后乳房重建及放射治疗后进行重大矫正手术的发生率。

Incidence of major corrective surgery after post-mastectomy breast reconstruction and radiation therapy.

作者信息

Wong Julia S, Ho Alice Y, Kaelin Carolyn M, Bishop Karyn L, Silver Barbara, Gelman Rebecca, Harris Jay R, Hergrueter Charles A

机构信息

Department of Radiation Oncology, Brigham and Women's Hospital/Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA.

出版信息

Breast J. 2008 Jan-Feb;14(1):49-54. doi: 10.1111/j.1524-4741.2007.00522.x.

Abstract

To evaluate the likelihood of requiring major corrective surgery (MCS) after modified radical mastectomy (MRM), immediate reconstruction and radiation therapy (RT) to the reconstructed breast. The study population consisted of 62 patients who underwent MRM and immediate breast reconstruction between 1990 and 1999, had postoperative radiation and at least one follow-up visit or procedure > or = 2 months after radiation. Reconstruction consisted of a pedicled transverse rectus abdominis myocutaneous flap in 42 patients, latissimus dorsi flap in five, latissimus dorsi plus implant in six, and implant alone in nine. Median follow-up time after reconstruction was 13 months (range: 2-58) for non-implant patients and 10 months (range: 4-57) for implant patients. The primary endpoint was the incidence of major complications requiring MCS. Ten patients (16%) underwent MCS between 1 and 28 months after radiation (median in these patients of 8 months). 4/47 non-implant patients (9%) underwent MCS, compared to 6/15 implant patients (40%). Of patients followed > or = 6 months after RT, 0/38 non-implant patients underwent MCS within 6 months compared to 3/13 (23%) implant patients (p = 0.01); of patients followed for > or = 12 months after RT, the rates of MCS within 12 months were 1/24 (4%) and 2/7 (29%), respectively (p = 0.12). Patients who undergo immediate reconstruction after mastectomy using an implant followed by radiation have a high rate of subsequent MCS. The difference in the rate of MCS between the implant and non-implant groups is significant in early follow-up. Patients considering an implant followed by RT should be apprised of this increased risk. Prospective studies of these risks and the cosmetic outcomes are warranted.

摘要

为评估改良根治性乳房切除术(MRM)后需要进行重大矫正手术(MCS)的可能性,以及对重建乳房进行即刻重建和放射治疗(RT)。研究人群包括1990年至1999年间接受MRM和即刻乳房重建、术后接受放射治疗且在放射治疗后至少有一次随访或检查且时间≥2个月的62例患者。重建方式包括42例患者采用带蒂腹直肌肌皮瓣、5例采用背阔肌皮瓣、6例采用背阔肌皮瓣加植入物、9例仅采用植入物。非植入物患者重建后的中位随访时间为13个月(范围:2 - 58个月),植入物患者为10个月(范围:4 - 57个月)。主要终点是需要进行MCS的重大并发症发生率。10例患者(16%)在放射治疗后1至28个月接受了MCS(这些患者的中位时间为8个月)。47例非植入物患者中有4例(9%)接受了MCS,而15例植入物患者中有6例(40%)。在放射治疗后随访≥6个月的患者中,38例非植入物患者在6个月内无人接受MCS,而13例植入物患者中有3例(23%)接受了MCS(p = 0.01);在放射治疗后随访≥12个月的患者中,12个月内MCS的发生率分别为24例中的1例(4%)和7例中的2例(29%)(p = 0.12)。乳房切除术后采用植入物即刻重建并随后进行放射治疗的患者,后续MCS的发生率较高。在早期随访中,植入物组和非植入物组之间MCS发生率的差异具有统计学意义。考虑采用植入物并随后进行放射治疗的患者应被告知这种风险增加。有必要对这些风险和美容效果进行前瞻性研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验